Search Results for: DNA VACCINES MARKET DNA Vaccines


November 19, 2015

SINGLE-USE MARKET – Rise of Single-Use Technologies & Systems in Biopharmaceuticals November 19, 2015

Kevin James and Shalini S. Dewan of BCC Research believe eliminating the risk of contamination is the greatest challenge faced by manufacturers of biopharmaceuticals, and currently, this requires high-level monitoring of critical manufacturing processes. Single-use technology aids biopharmaceutical manufacturers in overcoming this challenge by reducing or eliminating the need for sterilization between batches, thereby improving operational efficiency.

June 26, 2019

Novavax & Catalent Biologics Enter Strategic Partnership June 26, 2019

Novavax, Inc. and Catalent Biologics’ Paragon Gene Therapy unit recently announced an arrangement under which Paragon Gene Therapy will assume the leases to two Novavax product development and manufacturing facilities, giving it immediate access to……..

April 15, 2019

Paragon Bioservices to be Acquired for $1.2 Billion April 15, 2019

Catalent, Inc. and Paragon Bioservices, Inc. and Catalent Inc. recently announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion.


May 2, 2018

January 2009

Monodisperse Microspheres for parenteral Drug Delivery Gert Veldhuis, PhD, and Mi­riam Gironess, PhD, MSc, review a novel manufacturing process that...